Echo Street Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Echo Street Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-27,565	Closed	-$1.25M	–	622
2022 Q4	$1.25M	Buy	27,565 +22,535	+448%	+$1.46M	0.01%	128
2022 Q3	$351K	Buy	+5,030	New	+$372K	﹤0.01%	362
2022 Q2	–	Sell	-5,584	Closed	-$459K	–	748
2022 Q1	$459K	Buy	+5,584	New	+$571K	﹤0.01%	423
2021 Q3	–	Sell	-4,996	Closed	-$807K	–	782
2021 Q2	$807K	Buy	4,996 +1,400	+39%	+$225K	0.01%	235
2021 Q1	$616K	Sell	3,596 -1,775	-33%	-$351K	0.01%	256
2020 Q4	$1.18M	Buy	+5,371	New	+$1.16M	0.01%	145
2020 Q3	–	Sell	-3,604	Closed	-$411K	–	390
2020 Q2	$411K	Buy	+3,604	New	+$350K	﹤0.01%	370

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Echo Street Capital Management's MRTX Position: Q1 2023 in Review

Echo Street Capital Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2023, closing a stake of 27,565 shares — an estimated $1.25M sold.

Echo Street Capital Management first reported a position in MRTX in Q2 2020 and held it in 7 quarters. The position peaked at $1.25M in Q4 2022. 221 funds tracked by Wall St. Rank hold MRTX as of Q1 2023.

Echo Street Capital Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Echo Street Capital Management sold 27,565 Mirati Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.25M.
Echo Street Capital Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Echo Street Capital Management's Mirati Therapeutics, Inc. Common Stock position peaked at $1.25M in Q4 2022.
221 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Echo Street Capital Management's 13F filing for Q1 2023, filed 15 May 2023.